EM1511J "Excess Mortality in Treated HIV Infection" (IM GR-112015)

This presentation discusses the maximum mortality benefit for people with HIV infection that can be achieved with modern combination antiretroviral therapy and the accuracy by which life expectancy estimates can be made. Finally it addresses implications of a recent worldwide change in treatment recommendations.

Download Protocol

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to

  • Describe current antiretroviral treatment recommendation for HIV infection.
  • Describe changes in HIV-related mortality that have occurred over the last 20 years.
  • Describe predictors for mortality for people on stable antiretroviral therapy.
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
11/30/2015
Course expires: 
12/30/2015
Cost:
$0.00

Photo: Henning Drechsler, M.D.Henning Drechsler, M.D.
Associate Professor of Internal Medicine
Division of Infectious Diseases

Available Credit

  • 1.00 AMA

Accreditation Period

Course opens: 
11/30/2015
Course expires: 
12/30/2015

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome